The Moderna Neoantigen selection. A tumor carries thousands of mutations. Only a handful produce peptides that get presented on MHC and recognized by T cells. Moderna’s pipeline takes next-generation sequencing data from tumor and blood samples, reviews the genetic mutations, and predicts up to 34 neoantigens most likely to elicit an immune response. That’s the ...

Read more

---

Link :
https://www.nextbigfuture.com/2026/08/not-yet-ai-curing-cancer-but-validating-gains-can-be-made.html